Rule 14 Aug 2025 regulation, administrative practice and procedure, reporting and recordkeeping requirements, small businesses, freedom of information, courts, uspto, intellectual property, inventions and patents, biologics, patents, design applications

⚖️Eliminating Expedited Examination of Design Applications

The United States Patent and Trademark Office (USPTO) previously suspended expedited examination of design applications effective April 17, 2025. Further to the suspension, the USPTO hereby amends the Rules of Practice in Patent Cases by removing the provisions in the Code of Federal Regulations that provide for expedited examination of design applications. The removal of those regulations supports the USPTO's efforts to reduce the pendency of unexamined design applications, which will benefit all design patent applicants. The removal also facilitates the USPTO's efforts to address the problem of erroneous micro entity certifications, as well as the USPTO's broader efforts to mitigate and protect against threats to the intellectual property system.

Learn More
Notice 4 Aug 2025 compliance, trade regulations, international trade commission, settlement, dermatological devices, patents

⚖️ITC Terminates Investigation on Dermatological Treatment Devices

Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 71) of the presiding administrative law judge ("ALJ"), granting an unopposed motion to terminate the remand proceedings. The investigation is terminated in its entirety.

Learn More
Notice 23 Jul 2025 compliance, regulatory, uspto, intellectual property, business feedback, patents, quality survey

📊USPTO Requests Comments on Patents External Quality Survey

The United States Patent and Trademark Office (USPTO) will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. The USPTO invites comments on the information collection renewal of 0651-0057 (Patents External Quality Survey), which helps the USPTO assess the impact of its information collection requirements and minimize the public's reporting burden. Public comments were previously requested via the Federal Register on May 1, 2025 during a 60-day comment period (90 FR 18648). This notice allows for an additional 30 days for public comments.

Learn More
Notice 15 May 2025 information collection, department of energy, licenses, patents, regulatory compliance, technology partnerships

📄DOE Notice on Technology Partnerships Ombudsmen Reporting Requirements

The Department of Energy (DOE) has submitted an information collection request to the OMB for extension under the provisions of the Paperwork Reduction Act of 1995. The information collection requests a three-year extension of its collection, titled Technology Partnerships Ombudsmen Reporting Requirements, OMB Control Number 1910-5118. The proposed collection will identify the number and nature of complaints received and resolved by technology partnership ombuds related to technology partnerships, patents, and licenses.

Learn More
Notice 7 May 2025 patents, u.s. international trade commission, import regulations, electronic devices, international trade

🖥️ITC Investigation on Electronic Devices and Patent Violations

Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to review in its entirety a final initial determination ("ID") of the presiding administrative law judge ("ALJ"), finding no violation of section 337. The Commission requests written submissions from the parties on the issues under review and submissions from the parties, interested government agencies, and other interested persons on the issues of remedy, the public interest, and bonding, under the schedule set forth below.

Learn More
Notice 2 May 2025 health, research, grants, drug delivery, patents

💉Correction Notice for Exclusive Patent License on Drug Delivery System

The Department of Health and Human Services corrected a previous notice regarding a prospective grant of an exclusive patent license for a macromolecular drug delivery platform. This announcement pertains specifically to its size-dependent brain and lymphatic distribution characteristics, aiming to facilitate drug delivery innovation.

Learn More
Notice 1 May 2025 patents, u.s. international trade commission, optical network equipment, business compliance, trade law, international trade

⚖️USITC Finds No Violation of Patent Claims in Optical Network Equipment Case

Notice is hereby given that the U.S. International Trade Commission has determined to find no violation of section 337 of the Tariff Act of 1930, as amended in the above-captioned investigation. The investigation is terminated.

Learn More
Notice 11 Apr 2025 trademarks, business programs, regulatory compliance, patents, humanitarian

🏅USPTO Notice

The United States Patent and Trademark Office (USPTO) will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. The USPTO invites comments on the information collection renewal of 0651-0066 (Patents for Humanity Program and Trademarks for Humanity Program), which helps the USPTO assess the impact of its information collection requirements and minimize the reporting burden on the public. Public comments were previously requested via the Federal Register on October 25, 2024, during a 60-day comment period (89 FR 85171). This notice allows for an additional 30 days for public comments.

Learn More